Shunzo Aibara

Title: Shunzo Aibara: Innovator in Anti-Allergic Compounds

Introduction

Shunzo Aibara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit anti-allergic properties. With a total of 6 patents to his name, Aibara's work has the potential to impact the treatment of various allergic conditions.

Latest Patents

Aibara's latest patents include innovative compounds such as tricyclic triazolopyrimidine derivatives. These novel compounds, represented by formula (I), are disclosed along with their physiologically acceptable salts. They demonstrate excellent anti-allergic activity and are useful for the treatment and prophylaxis of allergic diseases. Another significant patent involves thiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidine, which also showcases triazolopyrimidine compounds with similar beneficial effects. These compounds are particularly effective in oral administration for treating conditions like bronchial asthma, allergic gastro-intestinal disorders, allergic rhinitis, hay fever, and urticaria.

Career Highlights

Shunzo Aibara is currently associated with Daiichi Seiyaku Co., Ltd., a leading pharmaceutical company. His work at the company has been instrumental in advancing research and development in the field of allergy treatments. Aibara's innovative approach and dedication to his work have earned him recognition in the industry.

Collaborations

Throughout his career, Aibara has collaborated with notable colleagues, including Tamotsu Miwa and Hiroshi Fujita. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Shunzo Aibara's contributions to the field of anti-allergic compounds highlight his role as a key inventor in the pharmaceutical industry. His innovative patents and collaborations continue to pave the way for advancements in allergy treatment.